Heme oxygenase-1: a novel key player in the development of tolerance in response to organic nitrates.
OBJECTIVE
Nitrate tolerance is likely attributable to an increased production of reactive oxygen species (ROS) leading to an inhibition of the mitochondrial aldehyde dehydrogenase (ALDH-2), representing the nitroglycerin (GTN) and pentaerythrityl tetranitrate (PETN) bioactivating enzyme, and to impaired nitric oxide bioactivity and signaling. We tested whether differences in their capacity to induce heme oxygenase-1 (HO-1) might explain why PETN and not GTN therapy is devoid of nitrate and cross-tolerance.


RESULTS
Wistar rats were treated with PETN or GTN (10.5 or 6.6 microg/kg/min for 4 days). In contrast to GTN, PETN did not induce nitrate tolerance or cross-tolerance as assessed by isometric tension recordings in isolated aortic rings. Vascular protein and mRNA expression of HO-1 and ferritin were increased in response to PETN but not GTN. In contrast to GTN therapy, NO signaling, ROS formation, and the activity of ALDH-2 (as assessed by an high-performance liquid chromatography-based method) were not significantly influenced by PETN. Inhibition of HO-1 expression by apigenin induced "tolerance" to PETN whereas HO-1 gene induction by hemin prevented tolerance in GTN treated rats.


CONCLUSIONS
HO-1 expression and activity appear to play a key role in the development of nitrate tolerance and might represent an intrinsic antioxidative mechanism of therapeutic interest.
Wenzel
Philip
P
II. Medizinische Klinik, Johannes-Gutenberg-Universität Mainz, Langenbeckstr. 1, 55131 Mainz, Germany.
Oelze
Matthias
M
Coldewey
Meike
M
Hortmann
Marcus
M
Seeling
Andreas
A
Hink
Ulrich
U
Mollnau
Hanke
H
Stalleicken
Dirk
D
Weiner
Henry
H
Lehmann
Jochen
J
Li
Huige
H
Förstermann
Ulrich
U
Münzel
Thomas
T
Daiber
Andreas
A
D000444:Aldehyde Dehydrogenase / Q000378:metabolism; D000818:Animals; D002851:Chromatography, High Pressure Liquid; D006152:Cyclic GMP / Q000378:metabolism; D004195:Disease Models, Animal; D004361:Drug Tolerance; D004730:Endothelium, Vascular / Q000187:drug effects; D016166:Free Radical Scavengers; D051547:Heme Oxygenase-1 / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D005996:Nitroglycerin / Q000378:metabolism / Q000494:pharmacology*; D010417:Pentaerythritol Tetranitrate / Q000378:metabolism / Q000494:pharmacology*; D011336:Probability; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D017382:Reactive Oxygen Species; D012016:Reference Values; D012680:Sensitivity and Specificity
D016166:Free Radical Scavengers; D017382:Reactive Oxygen Species; D010417:Pentaerythritol Tetranitrate; D051547:Heme Oxygenase-1; D000444:Aldehyde Dehydrogenase; D005996:Nitroglycerin; D006152:Cyclic GMP